| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 12.90▼ | 12.90▼ | 12.89▼ | 12.78▲ | 12.81▲ |
| MA10 | 12.90▼ | 12.90▼ | 12.88▼ | 12.78▲ | 12.88▼ |
| MA20 | 12.90▼ | 12.87▼ | 12.84▲ | 12.79▲ | 13.04▼ |
| MA50 | 12.86▼ | 12.78▲ | 12.81▲ | 12.92▼ | 13.07▼ |
| MA100 | 12.79▲ | 12.82▲ | 12.82▲ | 13.09▼ | 12.97▼ |
| MA200 | 12.82▲ | 12.84▲ | 12.85▲ | 13.04▼ | 12.38▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.006▼ | -0.004▼ | 0.005▲ | 0.013▲ | -0.030▼ |
| RSI | 39.945▼ | 51.459▲ | 54.394▲ | 51.945▲ | 47.014▼ |
| STOCH | 72.222 | 57.474 | 68.894 | 41.880 | 22.807 |
| WILL %R | -100.000▼ | -57.143 | -51.613 | -28.205 | -68.889 |
| CCI | -282.456▼ | -21.307 | 30.430 | 85.784 | -39.779 |
|
Monday, February 09, 2026 07:32 AM
(RTTNews) - Biofrontera Inc. (BFRI) announced positive and statistically significant top-line results from its Phase 3 clinical trial evaluating Ameluz photodynamic therapy (PDT) with RhodoLED ...
|
|
Monday, February 09, 2026 06:46 AM
(RTTNews) - Biofrontera Inc. (BFRI), Monday announced positive and statistically significant top-line results from its Phase 3 clinical trial, evaluating Ameluz PDT with the red-light LEDplatform for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/06/26 | 12.85 | 12.94 | 12.85 | 12.86 | 127,236 |
| 26/06/26 | 12.80 | 12.88 | 12.80 | 12.84 | 151,826 |
| 25/06/26 | 12.73 | 12.965 | 12.725 | 12.76 | 129,440 |
| 24/06/26 | 12.71 | 12.79 | 12.71 | 12.73 | 85,234 |
| 23/06/26 | 12.61 | 12.695 | 12.58 | 12.69 | 118,800 |
| 22/06/26 | 12.71 | 12.8799 | 12.61 | 12.61 | 173,032 |
| 18/06/26 | 12.75 | 12.8799 | 12.68 | 12.72 | 169,502 |
| 17/06/26 | 12.85 | 12.89 | 12.71 | 12.72 | 112,776 |
| 16/06/26 | 12.96 | 12.97 | 12.85 | 12.88 | 71,911 |
| 15/06/26 | 12.85 | 12.97 | 12.8101 | 12.95 | 77,873 |
|
|
||||
|
|
||||
|
|